VictoryShares Free Cash Flow ETF (VFLO)
| Assets | $6.59B |
| Expense Ratio | 0.39% |
| PE Ratio | 18.99 |
| Shares Out | 158.52M |
| Dividend (ttm) | $0.55 |
| Dividend Yield | 1.31% |
| Ex-Dividend Date | Apr 9, 2026 |
| Payout Frequency | Monthly |
| Payout Ratio | 24.84% |
| Volume | 256,742 |
| Open | 41.88 |
| Previous Close | 41.91 |
| Day's Range | 41.70 - 42.14 |
| 52-Week Low | 32.31 |
| 52-Week High | 42.37 |
| Beta | 0.81 |
| Holdings | 52 |
| Inception Date | Jun 21, 2023 |
About VFLO
Fund Home PageThe VictoryShares Free Cash Flow ETF (VFLO) is an exchange-traded fund that is based on the Victory US Large Cap Free Cash Flow index. The fund tracks an index composed of the largest U.S. companies based on profit that are perceived to have strong free cash flow yields and high growth metrics VFLO was launched on Jun 21, 2023 and is issued by VictoryShares.
Top 10 Holdings
31.67% of assets| Name | Symbol | Weight |
|---|---|---|
| Sandisk Corporation | SNDK | 4.41% |
| Dell Technologies Inc. | DELL | 3.72% |
| The Cigna Group | CI | 3.32% |
| Omnicom Group Inc. | OMC | 3.23% |
| Salesforce, Inc. | CRM | 2.99% |
| Zoom Communications, Inc. | ZM | 2.98% |
| Adobe Inc. | ADBE | 2.89% |
| Accenture plc | ACN | 2.78% |
| Expedia Group, Inc. | EXPE | 2.73% |
| Newmont Corporation | NEM | 2.61% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Apr 9, 2026 | $0.03332 | Apr 10, 2026 |
| Mar 10, 2026 | $0.04956 | Mar 11, 2026 |
| Dec 11, 2025 | $0.15019 | Dec 12, 2025 |
| Nov 7, 2025 | $0.02497 | Nov 10, 2025 |
| Oct 9, 2025 | $0.03953 | Oct 10, 2025 |
| Sep 8, 2025 | $0.14648 | Sep 9, 2025 |
Performance
VFLO had a total return of 28.77% in the past year, including dividends. Since the fund's inception, the average annual return has been 21.86%.
News
Why Free Cash Flow Should Be Front of Mind in Today's Market
In a market where the Magnificent Seven (Mag 7)1 account for more than 30% of the S&P 500 Index, The VictoryShares free cash flow (FCF) suite of ETFs takes a different road.
Are Pharmaceuticals Poised for a Rebound? The Key Metric to Keep in Mind
Are Pharmaceuticals Poised for a Rebound? The Key Metric to Keep in Mind With pharmaceutical M&A ramping up and robust pipelines with high impact launches on the horizon, investors may be considering ...
Evaluating Equity Exposure Through the Free Cash Flow Lens
Investors have no shortage of metrics to evaluate equities, but not all measures capture the same economic reality. In an environment defined by elevated capital spending and market concentration, ear...
Three key ETF investing themes to watch in 2026
They say there's no rest for the weary and ETF investors are no exception. BlackRock U.S. head of equity ETFs Jay Jacobs tells CNBC's Dominic Chu on “ETF Edge” there are three key ETF themes to keep a...